Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity”.
Pedro A Lamothe, Caterina E. Faliti, Narayanaiah Cheedarla, Alberto Moreno, Mehul S Suthar +35 more